Pictet Asset Management
AMLX icon

Pictet Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Pictet Asset Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Hold
10,768
– – ﹤0.01% 2011
2026
Q1 		$150K Buy
+10,768
New +$151K ﹤0.01% 1987

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Pictet Asset Management's AMLX Position: Q2 2026 in Review

Pictet Asset Management held its Amylyx Pharmaceuticals (AMLX) position steady in Q2 2026 at 10,768 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Pictet Asset Management first reported a position in AMLX in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Pictet Asset Management held 10,768 shares of Amylyx Pharmaceuticals worth $193K as of Q2 2026.
  • Pictet Asset Management left its Amylyx Pharmaceuticals share count unchanged in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #2011 holding.
  • Pictet Asset Management first reported a position in Amylyx Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 57 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.